Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity

Journal of Experimental Medicine

Volumn 186, Issue 8, 1997, Pages 1247-1256

  Song, Wenru ^a   Kong, Hwai Loong ^a   Carpenter, Heather ^a   Torii, Hideshi ^a   Granstein, Richard ^a   Rafii, Shahin ^a   Moore, Malcolm A S ^b   Crystal, Ronald G ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; BETA GALACTOSIDASE; COMPLEMENTARY DNA; MAJOR HISTOCOMPATIBILITY ANTIGEN; VIRUS VECTOR;

ADENOVIRUS; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; GENE EXPRESSION; GENE TRANSFER; IMMUNE RESPONSE; IMMUNIZATION; MALE; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; SURVIVAL; TUMOR; TUMOR IMMUNITY;

ADENOCARCINOMA; ADENOVIRIDAE; ANIMALS; BETA-GALACTOSIDASE; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CELL LINE; COLONIC NEOPLASMS; DENDRITIC CELLS; DNA, COMPLEMENTARY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; IMMUNOTHERAPY, ADOPTIVE; LUNG NEOPLASMS; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED BALB C; MODELS, IMMUNOLOGICAL; NEOPLASM TRANSPLANTATION; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0030856119     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.186.8.1247     Document Type: Article

References (46)

1. Pardoll, D.M. 1993. Cancer vaccines. Immunol. Today. 14: 310-316.
2. Houghton, A.N. 1994. Cancer antigens: immune recognition of self and altered self. J. Exp. Med. 180:1-4.
3. Boon, T., and P. van der Bruggen. 1996. Human tumor antigens recognized by T lymphocytes. J. Exp. Med. 183:725-729.
4. Juillard, V., P. Villefroy, D. Godfrin, A. Pavirani, A. Venet, and J.G. Guillet. 1995. Long-term humoral and cellular immunity induced by a single immunization with replication-defective adenovirus recombinant vector. Eur. J. Immunol. 25:3467-3473.
5. Chen, P.W., M. Wang, V. Bronte, Y. Zhai, S.A. Rosenberg, and N.P. Restifo. 1996. Therapeutic antitumor response after immunization with a recombinant adenovirus encoding a model tumor-associated antigen. J. Immunol. 156:224-231.
6. Xiang, Z.Q., Y. Yang, J.M. Wilson, and H.C. Ertl. 1996. A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier, Virology. 219:220-227.
7. Flanagan, B., C.R. Pringle, and K.N. Leppard. 1997. A recombinant adenovirus expressing the simian immunodeficiency virus Gag antigen can induce long-lived immune responses in mice. J. Gen. Virol. 78:991-997.
8. Rodriques, E.G., F. Zavala, D. Eichinger, J.M. Wilson, and M. Tsuji. 1997. Single immunizing dose of recombinant adenovirus efficiently induces CD8+ T cell-mediated protective immunity against malaria. J. Immunol. 158:1268-1274.
9. Song, W., H. Kong, P. Traktman, and R.G. Crystal. 1997. Cytotoxic T lymphocyte responses to proteins encoded by heterologous transgenes transferred in vivo by adenoviral vectors. Hum. Gene Ther. 8:1207-1217.
10. Germain, R.N. 1994. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell. 76:287-299.
11. Bevan, M.J. 1995. Antigen presentation to cytotoxic T lymphocytes in vivo. J. Exp. Med. 182:639-641.
12. Steinman, R.M. 1991. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9:271-296.
13. Grabbe, S., S. Beissert, T. Schwarz, and R.D. Granstein. 1995. Dendritic cells as initiators of tumor immune responses: a possible strategy for tumor immunotherapy? Immunol. Today. 16:117-12.
14. Young, J.W., and K. Inaba. 1996. Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity. J. Exp. Med. 183:7-11.
15. Steinman, R.M. 1997. Dendritic cells and immune-based therapies. Exp. Hematol. (NY). 24:859-862.
16. Xu, S., P.R. Bergstresser, and A. Takashima. 1995. Phenotypic and functional heterogeneity among murine epidermal-derived dendritic cell clones. J. Invest. Dermatol. 105:831-836.
17. Xu, S., K. Ariizumi, G. Caceres-Dittmar, D. Edelbaum, K. Hashimoto, P.R. Bergstresser, and A. Takashinia. 1995. Successive generation of antigen-presenting, dendritic cell lines from murine epidermis. J. Immunol. 154:2697-2705.
18. Wang, M., V. Bronte, P.W. Chen, L. Gritz, D. Panicali, S.A. Rosenberg, and N.P. Restifo. 1995. Active immunotherapy of cancer with a nonreplicating recombinant fowlpox virus encoding a model tumor-associated antigen. J. Immunol. 154: 4685-4692.
19. Rawle, F.C., B.B. Knowles, R.P. Ricciardi, V. Brahmacheri, P. Duerksen-Hughes, W.S. Wold, and L.R. Gooding. 1991. Specificity of the mouse cytotoxic T lymphocyte response to adenovirus 5. E1a is immunodominant in H-2b, but not in H-2d or H-2k mice. J. Immunol. 146:3977-3984.
20. Inaba, K., M. Inaba, M. Deguchi, K. Hagi, R. Yasumizu, S. Ikehara, S. Muramatsu, and R.M. Steinman. 1993. Granulocytes, macrophages, and dendritic cells arise from a common major histocompatibility complex class II-negative progenitor in mouse bone marrow. Proc. Natl. Acad. Sci. USA. 90: 3038-3042.
21. Rosenfeld, M.A., W. Siegfried, K. Yoshimura, K. Yoneyama, M. Fukayama, L.E. Stier, P.K. Paakko, P. Gilardi, L.D. Stratford-Perricaudet, M. Perricaudet, et al. 1991. Adenovirus-mediated transfer of a recombinant alpha 1-antitrypsin gene to the lung epithelium in vivo. Science (Wash. DC). 252: 431-434.
22. Rosenfeld, M.A., K. Yoshimura, B.C. Trapnell, K. Yoneyama, E.R. Rosenthal, W. Dalemans, M. Fukayama, J. Bargon, L.E. Stier, L. Stratford-Perricaudet, et al. 1992. In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell. 68:143-155.
23. Hersh, J., R.G. Crystal, and B. Bewig. 1995. Modulation of gene expression after replication-deficient, recombinant adenovirus-mediated gene transfer by the product of a second adenovirus vector. Gene Ther. 2:124-131.
24. Crystal, R.G., N.G. McElvaney, M.A. Rosenfeld, C.S. Chu, A. Mastrangeli, J.G. Hay, S.L. Brody, H.A. Jaffe, N.T. Eissa, and C. Danel. 1994. Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nat. Genet. 8:42-51.
25. MacGregor, G.R., G.P. Nolan, S. Fiering, M. Roederer, and L.A. Herzenberg. 1991. Use of E. coli lacZ (β-galactosiclase) as a reporter gene. In Methods in Molecular Biology. E.J. Murray, editor. The Humana Press Inc., Clifton, NJ. 217-235.
26. Gavin, M.A., M.J. Gilbert, S.R. Riddell, P.D. Greenberg, and M.J. Bevan. 1993. Alkali hydrolysis of recombinant proteins allows for the rapid identification of class I MHC-restricted CTL epitopes. J. Immunol. 151:3971-3980.
27. Mack, C.A., W.R. Song, H. Carpenter, T.J. Wickham, I. Kovesdi, B.G. Harvey, C.J. Magovern, O.W. Isom, T. Rosengart, E. Falck-Pedersen, et al. 1997. Circumvention of anti-adenovirus neutralizing immunity by administration of an adenoviral vector of an alternate serotype. Hum. Gene Ther. 8:99-109.
28. Peto, R., M.C. Pike, P. Armitage, N.E. Breslow, D.R. Cox, S.V. Howard, N. Mantel, K. McPherson, J. Peto, and P.G. Smith. 1977. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br. J. Cancer. 35:1-39.
29. Grabbe, S., S. Bruvers, R.L. Gallo, T.L. Knisely, R. Nazareno, and R.D. Granstein. 1991. Tumor antigen presentation by murine epidermal cells. J. Immunol. 146:3656-3661.
30. Mayordomo, J.I., T. Zorina, W.J. Storkus, L. Zitvogel, C. Celluzzi, L.D. Falo, C.J. Melief, S.T. Ildstad, W.M. Kast, A.B. DeLeo, et al. 1995. Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity. Nat. Med. 1:1297-1302.
31. Ossevoort, M.A., M.C. Feltkamp, K.J. van Veen, C.J. Melief, and W.M. Kast. 1995. Dendritic cells as carriers for a cytotoxic T-lymphocyte epitope-based peptide vaccine in protection against a human papillomavirus type 16-induced tumor. J. Immunother. Emphasis Tumor Immunol. 18:86-94.
32. Boczkowski, D., S.K. Nair, D. Snyder, and E. Gilboa. 1996. Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo. J. Exp. Med. 184:465-472.
33. Celluzzi, C.M., J.I. Mayordomo, W.J. Storkus, M.T. Lotze, and L.D. Falo. 1996. Peptide-pulsed dendritic cells induce antigen-specific, CTL-mediated protective tumor immunity. J. Exp. Med. 183:283-287.
34. Hsu, F.J., C. Benike, F. Fagnoni, T.M. Liles, D. Czerwinski, B. Taidi, E.G. Engleman, and R. Levy. 1996. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat. Med. 2:52-58.
35. Mayordomo, J.I., D.J. Loftus, H. Sakamoto, C.M. De Cesare, P.M. Appasamy, M.T. Lotze, W.J. Storkus, E. Appella, and A.B. De Leo. 1996. Therapy of murine tumors with p53 wild-type and mutant sequence peptide-based vaccines. J. Exp. Med. 183:1357-1365.
36. Paglia, P., C. Chiodoni, M. Rodolfo, and M.P. Colombo. 1996. Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo. J. Exp. Med. 183:317-322.
37. Porgador, A., D. Snyder, and E. Gilboa. 1996. Induction of antitumor immunity using bone marrow-generated dendritic cells. J. Immunol. 156:2918-2926.
38. Zitvogel, L., J.I. Mayordomo, T. Tjandrawan, A.B. DeLeo, M.R. Clarke, M.T. Lotze, and W.J. Storkus. 1996. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines. J. Exp. Med. 183:87-97.
39. Yang, Y., Q. Li, H.C.J. Ertl, and J.M. Wilson. 1995. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69:2004-2015.
40. Henderson, R.A., M.T. Nimgaonkar, S.C. Watkins, P.D. Robbins, E.D. Ball, and O.J. Finn. 1996. Human dendritic cells genetically engineered to express high levels of the human epithelial tumor antigen mucin (MUC-1). Cancer Res. 56:3763-3770.
41. Reeves, M.E., R.E. Royal, J.S. Lam, S.A. Rosenberg, and P. Hwu. 1996. Retroviral transduction of human dendritic cells with a tumor-associated antigen gene. Cancer Res. 56:5672-5677.
42. Wan, Y., J. Bramson, R. Cater, F. Graham, and J. Gauldie. 1996. Dendritic cells transfected with adenovirus vectors encoding a model tumor-associated antigen for tumor immunotherapy. Cold Spring Harbor - Gene Therapy Meeting, Cold Spring Harbor, NY. 316. (Abstr.).
43. Aicher, A., J. Westermann, S. Cayeux, G. Willimsky, K. Daemen, T. Blankenstein, W. Uckert, B. Dorken, and A. Pezzutto. 1997. Successful retroviral mediated transduction of a reporter gene in human dendritic cells: feasibility of therapy with gene-modified antigen presenting cells. Exp. Hematol. (NY). 25:39-44.
44. Brossart, P., A.W. Goldrath, E.A. Butz, S. Martin, and M.J. Bevan. 1997. Virus-mediated delivery of antigenic epitopes into dendritic cells as a means to induce CTL. J. Immunol. 158:3270-3276.
45. Fisher, B. 1992. The evolution of paradigms for the management of breast cancer: a personal perspective. Cancer Res. 52: 2371-2383.
46. Fidler, I.J. 1995. Invasion and metastasis. In Clinical Oncology. M.D. Abeloff, J.O. Armitage, A.S. Lichter, and J.E. Niederhuber, editors. Churchill Livingstone, New York. 55-76.